APA

Li F., Zhu Z., Xue M., He W., Zhang T., Feng L. & Lin S. (20190731). siRNA-based breast cancer therapy by suppressing 17β-hydroxysteroid dehydrogenase type 1 in an optimized xenograft cell and molecular biology model in vivo. : Drug design, development and therapy.

Chicago

Li Fang, Zhu ZhiHan, Xue Man, He WanHong, Zhang Ting, Feng LingLin and Lin ShengXiang. 20190731. siRNA-based breast cancer therapy by suppressing 17β-hydroxysteroid dehydrogenase type 1 in an optimized xenograft cell and molecular biology model in vivo. : Drug design, development and therapy.

Harvard

Li F., Zhu Z., Xue M., He W., Zhang T., Feng L. and Lin S. (20190731). siRNA-based breast cancer therapy by suppressing 17β-hydroxysteroid dehydrogenase type 1 in an optimized xenograft cell and molecular biology model in vivo. : Drug design, development and therapy.

MLA

Li Fang, Zhu ZhiHan, Xue Man, He WanHong, Zhang Ting, Feng LingLin and Lin ShengXiang. siRNA-based breast cancer therapy by suppressing 17β-hydroxysteroid dehydrogenase type 1 in an optimized xenograft cell and molecular biology model in vivo. : Drug design, development and therapy. 20190731.